Correspondence on “Early dynamics of clinical and laboratory parameters predict primary refractory disease in patients with metastatic urothelial carcinoma receiving atezolizumab”by Graser et al
| Published in: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Online Access: | https://jitc.bmj.com/content/13/6/e012582.full |
